PEDRO PIEDRA to Dose-Response Relationship, Immunologic
This is a "connection" page, showing publications PEDRO PIEDRA has written about Dose-Response Relationship, Immunologic.
Connection Strength
0.156
-
A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age. J Infect Dis. 2016 Feb 01; 213(3):411-22.
Score: 0.121
-
A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age. Vaccine. 2017 06 27; 35(30):3749-3759.
Score: 0.034